GymNation is turning heads with its latest concept — an in-gym hotel promising recovery without the commute. Dumbbell-shaped towels, protein-on-demand, and "Gymflix" are just the beginning. Is this the future of fitness, or something a little more tongue-in-cheek?

Novo Nordisk says unauthorized compounded versions of Wegovy are cutting into U.S. sales and warns it may pursue legal action to protect its intellectual property. The company has also expanded access to its official savings program.

New AI-powered research suggests that GLP-1 drugs, commonly used for diabetes and obesity, could prevent up to 34,000 heart attacks and strokes annually by offering cardiovascular benefits to millions of Americans.

Discover the latest breakthrough in obesity treatment as Novo Nordisk launches Wegovy® in Canada on May 6, 2024. Learn how this once-weekly injection can transform obesity management and support millions of Canadians. Explore the effectiveness, safety data, and patient eligibility for Wegovy®.